{"DataElement":{"publicId":"3357416","version":"1","preferredName":"Disease or Disorder FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Diagnosis Value","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._Value; a numerical quantity measured or assigned or computed.","longName":"3357406v1.0:3357408v1.0","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"3357406","version":"1","preferredName":"Disease or Disorder FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Diagnosis","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"2404658v1.0:3357404v1.0","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3357404","version":"1","preferredName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Diagnosis","preferredDefinition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C99408:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms","conceptCode":"C99408","definition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D4B2E6-1825-5F56-E040-BB89AD434EB4","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D4B2E6-1836-5F56-E040-BB89AD434EB4","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to GOG for REBOYJ by script Thu Aug 1 14:45:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3357408","version":"1","preferredName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Value","preferredDefinition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._Value; a numerical quantity measured or assigned or computed.","longName":"3357408v1.0","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"6","valueDescription":"WHO Score of 6","ValueMeaning":{"publicId":"3357409","version":"1","preferredName":"WHO Score of 6","longName":"3357409","preferredDefinition":"WHO Score of 6","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D4DFD3-2486-72BC-E040-BB89AD437893","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6D4DFD3-249F-72BC-E040-BB89AD437893","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","deletedIndicator":"No"},{"value":"5","valueDescription":"WHO Score of 5","ValueMeaning":{"publicId":"3357410","version":"1","preferredName":"WHO Score of 5","longName":"3357410","preferredDefinition":"WHO Score of 5","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D4DFD3-24A9-72BC-E040-BB89AD437893","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6D4DFD3-24C2-72BC-E040-BB89AD437893","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","deletedIndicator":"No"},{"value":"4","valueDescription":"WHO Score of 4","ValueMeaning":{"publicId":"3357411","version":"1","preferredName":"WHO Score of 4","longName":"3357411","preferredDefinition":"WHO Score of 4","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D4DFD3-24CC-72BC-E040-BB89AD437893","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6D4DFD3-24E5-72BC-E040-BB89AD437893","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","deletedIndicator":"No"},{"value":"3","valueDescription":"WHO Score of 3","ValueMeaning":{"publicId":"3357412","version":"1","preferredName":"WHO Score of 3","longName":"3357412","preferredDefinition":"WHO Score of 3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D4DFD3-24EF-72BC-E040-BB89AD437893","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6D4DFD3-2508-72BC-E040-BB89AD437893","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","deletedIndicator":"No"},{"value":"2","valueDescription":"WHO Score of 2","ValueMeaning":{"publicId":"3357413","version":"1","preferredName":"WHO Score of 2","longName":"3357413","preferredDefinition":"WHO Score of 2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D4DFD3-2512-72BC-E040-BB89AD437893","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6D4DFD3-252B-72BC-E040-BB89AD437893","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","deletedIndicator":"No"},{"value":"1","valueDescription":"WHO Score of 1","ValueMeaning":{"publicId":"3357414","version":"1","preferredName":"WHO Score of 1","longName":"3357414","preferredDefinition":"WHO Score of 1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D4DFD3-2535-72BC-E040-BB89AD437893","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6D4DFD3-254E-72BC-E040-BB89AD437893","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","deletedIndicator":"No"},{"value":"0","valueDescription":"WHO Score of 0","ValueMeaning":{"publicId":"3357415","version":"1","preferredName":"WHO Score of 0","longName":"3357415","preferredDefinition":"WHO Score of 0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D4DFD3-2558-72BC-E040-BB89AD437893","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6D4DFD3-2571-72BC-E040-BB89AD437893","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3357407","version":"1","preferredName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Value","preferredDefinition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk.:Value; a numerical quantity measured or assigned or computed.","longName":"C99408:CL052797","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms","conceptCode":"C99408","definition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"CL052797","definition":"Value; a numerical quantity measured or assigned or computed.","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D4DFD3-2461-72BC-E040-BB89AD437893","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D4DFD3-2472-72BC-E040-BB89AD437893","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2013-08-01","changeDescription":" Changed from CTEP to GOG for REBOYJ by script Thu Aug 1 14:45:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104991","version":"1","longName":"GOG-0275","context":"NRG"}]}],"AlternateNames":[{"name":"3357406v1.0:3357408v1.0","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"What is the patient's WHO sco","type":"Preferred Question Text","description":"What is the patient's WHO score?","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D4B2E6-185E-5F56-E040-BB89AD434EB4","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"FORMBUILDER","dateModified":"2014-09-02","changeDescription":" Changed from CTEP to GOG for REBOYJ by script Thu Aug 1 14:45:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}